Related Experiment Video

Updated: Sep 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Adult respiratory distress syndrome (ARDS) due to bacteraemic pneumococcal pneumonia

G P Mannes1, W G Boersma, C H Baur

  • 1Dept of Pulmonary Diseases, University Hospital Groningen, The Netherlands.

The European Respiratory Journal
|April 1, 1991
PubMed

Insights

Pneumococcal pneumonia with adult respiratory distress syndrome (ARDS) is a rare but serious complication. This condition, often caused by Streptococcus pneumoniae, carries a high mortality rate despite intensive treatment.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Streptococcus pneumoniae is a leading cause of community-acquired pneumonia.
  • Pneumococcal pneumonia can lead to severe complications such as adult respiratory distress syndrome (ARDS).
  • Bacteraemic pneumococcal pneumonia presents a significant clinical challenge with high mortality rates.

Observation:

  • This case report details a patient with no prior health conditions who developed bacteraemic pneumococcal pneumonia complicated by ARDS.
  • The patient received intensive treatment, including antibiotics.

Findings:

  • Adult respiratory distress syndrome (ARDS) is a rare complication of pneumococcal pneumonia.
  • Pneumococcal bacteraemia, found in 25-35% of pneumonia cases, increases mortality risk 2-3 fold compared to non-bacteraemic cases.
  • Despite modern medical interventions, mortality for this severe infection remains high.

Implications:

  • Highlights the critical need for prompt diagnosis and aggressive management of pneumococcal pneumonia, especially when bacteraemia is present.
  • Emphasizes the potential severity of Streptococcus pneumoniae infections and the challenges in treating associated complications like ARDS.
  • Underscores the importance of continued research into more effective treatments and preventative strategies for severe pneumococcal infections.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...